Coleen Davis
Family Medicine · Lees Summit, MONPI 1932342433
Payments from drug & device makers
Across 207 payments — averaging $17.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$584
- AstraZeneca$502
- AbbVie$382
- Lilly USA, LLC$328
- Teva Pharmaceuticals USA, Inc.$191
- Boehringer Ingelheim$178
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,525100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 39 | $584 |
| AstraZeneca(2 entities) | 27 | $502 |
| AbbVie | 20 | $382 |
| Lilly USA, LLC | 22 | $328 |
| Teva Pharmaceuticals USA, Inc. | 12 | $191 |
| Boehringer Ingelheim | 11 | $178 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $154 |
| Amgen | 10 | $152 |
| E.r. Squibb & Sons, L.L.C. | 6 | $112 |
| Dexcom, Inc. | 4 | $105 |
| Eisai Inc. | 6 | $89 |
| Johnson & Johnson | 5 | $79 |
| Exact Sciences | 5 | $76 |
| Pfizer | 5 | $74 |
| Merck | 4 | $72 |
| Novartis | 4 | $70 |
| Abbott | 4 | $60 |
| Astellas Pharma US Inc | 3 | $54 |
| Endogastric Solutions, Inc | 1 | $40 |
| Hologic Sales And Service, LLC | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $37 |
| Boston Scientific | 2 | $35 |
| Sanofi-aventis U.S. LLC | 1 | $32 |
| Bayer | 2 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Electromed, Inc. | 1 | $14 |
How this compares
$3,525 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 83 | $60,786 |
| OzempicSemaglutide | 40 | $58,300 |
| EliquisApixaban | 54 | $44,620 |
| TrulicityDulaglutide | 18 | $27,610 |
| RybelsusSemaglutide | 21 | $27,268 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 39 | $24,544 |
| Repatha SureclickEvolocumab | 33 | $23,412 |
| XareltoRivaroxaban | 21 | $22,658 |
| Nurtec OdtRimegepant Sulfate | 14 | $20,843 |
| JanuviaSitagliptin Phosphate | 17 | $15,506 |
| FarxigaDapagliflozin Propanediol | 15 | $12,448 |
| Tresiba Flextouch U-200Insulin Degludec | 12 | $10,950 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $8,214 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 13 | $6,190 |
| Gabapentin | 155 | $3,254 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $584 | $85,56861 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $178 | $66,97696 claims |
| PfizerEliquis, Nurtec Odt | $74 | $65,46368 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $502 | $36,99254 claims |
| Lilly USA, LLCTrulicity | $328 | $27,61018 claims |
| Johnson & JohnsonXarelto | $79 | $22,65821 claims |
| MerckJanuvia | $72 | $15,50617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Lees Summit
- Veronica AnwuriLees Summit$31K
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.